Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7501 USD | -6.84% | +4.82% | +0.96% |
05-13 | Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M | MT |
05-13 | Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 41.01M | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+60.01% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+4.57% | 8.79B |
- Stock Market
- Equities
- CARA Stock
- News Cara Therapeutics, Inc.
- BofA Downgrades Cara Therapeutics to Underperform From Neutral, Adjusts Price Target to $6 From $13